Comparison of incidence of peritonitis between peritoneal dialysis solution types

Nephron - Clinical Practice

Volumn 106, Issue 1, 2007, Pages

  Duranay, Murat ^a   Kanbay, Mehmet ^a,b   Turgut, Faruk ^b   Altay, Mustafa ^a   Akcay, Ali ^b  

^a Ankara Research and Training Hospital ^*  (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

Albumin; Extraneal; Glucose solutions; Nutrineal; Peritonitis

Indexed keywords

ALBUMIN; EXTRANEAL; GLUCOSE; NUTRINEAL; PERITONEAL DIALYSIS FLUID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONITIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; INCIDENCE; MALE; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TURKEY;

EID: 34247869685     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101485     Document Type: Article

References (15)

1. Piraino B: Infectious complications of peritoneal dialysis. Perit Dial Int 1997;7(suppl 3):S15-S18.
2. Vas S, Oreopoulos DG: Infections in patients undergoing peritoneal dialysis. Infect Dis Clin North Am 2001;15:743-774.
3. Martikainen TA, Teppo AM, Gronhagen-Riska C, Ekstrand AV: Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 2005;25:453-460.
4. Coban E, Ozdogan M, Tuncer M, Bozcuk H, Ersoy F: The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis. J Nephrol 2004;25:427-430.
5. Gokal R, Mallick NP: Peritoneal dialysis. Lancet 1999;353:823-828.
6. Johnson CC, Baldessarre J, Levison ME: Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin Infect Dis 1997;24:1035-1045.
7. Tintillier M, Pochet JM, Christophe JL, Scheiff JM, Goffin E: Transient sterile chemical peritonitis with icodextrin: clinical presentation, prevalence, and literature review. Perit Dial Int 2002;22:534-537.
8. Basile C, De Padova F, Montanaro A, Giordano R: The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome. J Nephrol 2003;16:384-386.
9. Boer WH, Vos PF, Fieren MW: Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis. Perit Dial Int 2003;23:33-38.
10. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J, et al: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991;17:462-471.
11. Churchill DN, Keshaviah PR, Taylor DW, et al, for the CANUSA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis; association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
12. Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimondo J: Urea kinetic analysis and clinical outcome on CAPD: a five year longitudinal study. Adv Perit Dial 1990;6:181-185.
13. Wang Q, Bernardini J, Piraino B, Fried L: Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003;41:664-669.
14. Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.
15. Cueto-Manzano AM, Gamba G, Correa-Rotter R: Quantification and characterization of protein loss in continuous ambulatory peritoneal dialysis. Rev Invest Clin 2000;52:611-617.